Here, we explain the facts behind several more of Robert F. Kennedy Jr.’s claims during his two Senate hearings as nominee ...

Recently, Sanofi-Aventis US LLC filed a lawsuit against the Department of Health and Human Services (HHS) and the Health Resources and Services Administration (HRSA) over changes to the 340B program.

Stefanie Spear, an HHS deputy chief of staff, instructed agency staff Tuesday morning to pause external communications, according to two people familiar with the discussions. Spear, who joined HHS ...

The first direction Tuesday was given by Stefanie Spear, a deputy chief of staff at HHS who joined the agency this week, according to the Post. Spear was the press secretary for Robert F.

The memo, which was sent to agency leaders by acting HHS Secretary Dorothy Fink, outlines that the HHS agencies should refrain from sending any documents for publication in the Federal Register ...

Kennedy Jr., President-elect Donald Trump’s pick for HHS secretary, undergoes Senate confirmation. Kennedy’s confirmation hearings are still not scheduled, and he is facing bipartisan pressure ...

Diabetes can lead to complications throughout the body and commonly causes digestive disorders such as gastroparesis (delayed emptying of the stomach). This can lead to stomach problems and pain.

The Washington Post: Trump Team Taps Dorothy Fink To Serve As Interim HHS Secretary Incoming Trump officials have tapped Dorothy Fink, an endocrinologist and career civil servant, as the interim ...

In most cases, people with type 2 diabetes can drink alcohol in moderate amounts. As you may well know, living with type 2 diabetes often means cutting out or cutting back on foods and beverages that ...

We sought to describe their association with euglycemic diabetic ketoacidosis (euDKA) in hopes that it will enhance recognition of this potentially life-threatening complication. Research Design ...

Unfortunately, there are no randomized prospective studies that have evaluated the optimal site of care for either DKA or HHS. Given the lack of such studies, the decision concerning the site of ...

No­var­tis is the lat­est drug­mak­er to sue the gov­ern­ment for al­leged­ly re­ject­ing its pro­posed mod­el to dis­trib­ute fed­er­al drug dis­counts.